Bevacizumab in first-line treatment of elderly patients with metastatic colorectal cancer: German community-based observational cohort study results
Saved in:
| Other Authors: | |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
2014
|
| In: |
BMC cancer
Year: 2014, Volume: 14 |
| ISSN: | 1471-2407 |
| Online Access: | Verlag, kostenfrei, Volltext: http://www.biomedcentral.com/1471-2407/14/761
|
| Author Notes: | Hofheinz, Ralf ... |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1502797607 | ||
| 003 | DE-627 | ||
| 005 | 20220811233412.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 150512s2014 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1186/1471-2407-14-761 |2 doi | |
| 035 | |a (DE-627)1502797607 | ||
| 035 | |a (DE-576)432797602 | ||
| 035 | |a (DE-599)BSZ432797602 | ||
| 035 | |a (OCoLC)1340691713 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 245 | 0 | 0 | |a Bevacizumab in first-line treatment of elderly patients with metastatic colorectal cancer |b German community-based observational cohort study results |c Hofheinz, Ralf ... |
| 264 | 1 | |c 2014 | |
| 300 | |a 10 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am: 12.05.2015 | ||
| 700 | 1 | |a Hofheinz, Ralf-Dieter |d 1969- |0 (DE-588)121917517 |0 (DE-627)08161876X |0 (DE-576)292991568 |4 oth | |
| 773 | 0 | 8 | |i In |t BMC cancer |d London : BioMed Central, 2001 |g 14(2014) Artikel-Nummer 761, 10 Seiten |h Online-Ressource |w (DE-627)326643710 |w (DE-600)2041352-X |w (DE-576)107014645 |x 1471-2407 |7 nnas |a Bevacizumab in first-line treatment of elderly patients with metastatic colorectal cancer German community-based observational cohort study results |
| 773 | 1 | 8 | |g volume:14 |g year:2014 |g extent:10 |a Bevacizumab in first-line treatment of elderly patients with metastatic colorectal cancer German community-based observational cohort study results |
| 856 | 4 | 0 | |u http://www.biomedcentral.com/1471-2407/14/761 |x Verlag |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20150512 | ||
| 993 | |a Article | ||
| 994 | |a 2014 | ||
| 998 | |g 121917517 |a Hofheinz, Ralf-Dieter |m 121917517:Hofheinz, Ralf-Dieter |d 60000 |d 61200 |e 60000PH121917517 |e 61200PH121917517 |k 0/60000/ |k 1/60000/61200/ |p 1 |x j | ||
| 999 | |a KXP-PPN1502797607 |e 2844343589 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"relHost":[{"title":[{"title":"BMC cancer","title_sort":"BMC cancer"}],"origin":[{"publisher":"BioMed Central ; Springer","publisherPlace":"London ; Berlin ; Heidelberg","dateIssuedDisp":"2001-","dateIssuedKey":"2001"}],"disp":"Bevacizumab in first-line treatment of elderly patients with metastatic colorectal cancer German community-based observational cohort study resultsBMC cancer","recId":"326643710","language":["eng"],"type":{"media":"Online-Ressource","bibl":"periodical"},"note":["Gesehen am 22.05.20"],"physDesc":[{"extent":"Online-Ressource"}],"id":{"zdb":["2041352-X"],"eki":["326643710"],"issn":["1471-2407"]},"part":{"volume":"14","extent":"10","year":"2014","text":"14(2014) Artikel-Nummer 761, 10 Seiten"},"pubHistory":["1.2001 -"]}],"note":["Gesehen am: 12.05.2015"],"id":{"doi":["10.1186/1471-2407-14-761"],"eki":["1502797607"]},"physDesc":[{"extent":"10 S."}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"name":{"displayForm":["Hofheinz, Ralf ..."]},"person":[{"given":"Ralf-Dieter","role":"oth","family":"Hofheinz","display":"Hofheinz, Ralf-Dieter"}],"language":["eng"],"origin":[{"dateIssuedKey":"2014","dateIssuedDisp":"2014"}],"recId":"1502797607","title":[{"title_sort":"Bevacizumab in first-line treatment of elderly patients with metastatic colorectal cancer","title":"Bevacizumab in first-line treatment of elderly patients with metastatic colorectal cancer","subtitle":"German community-based observational cohort study results"}]} | ||
| SRT | |a BEVACIZUMA2014 | ||